Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)

Rani Therapeutics Holdings has reported Debt Ratio over the past 6 years, most recently at 1.34 for Q3 2025.

  • Quarterly results put Debt Ratio at 1.34 for Q3 2025, up 105.38% from a year ago — trailing twelve months through Sep 2025 was 1.34 (up 105.38% YoY), and the annual figure for FY2024 was 0.67, up 32.44%.
  • Debt Ratio for Q3 2025 was 1.34 at Rani Therapeutics Holdings, up from 1.02 in the prior quarter.
  • Over the last five years, Debt Ratio for RANI hit a ceiling of 1.34 in Q3 2025 and a floor of 0.0 in Q2 2022.
  • Median Debt Ratio over the past 5 years was 0.38 (2023), compared with a mean of 0.43.
  • Biggest five-year swings in Debt Ratio: tumbled 97.86% in 2021 and later skyrocketed 121791.07% in 2023.
  • Rani Therapeutics Holdings' Debt Ratio stood at 0.0 in 2021, then surged by 26499.1% to 0.27 in 2022, then surged by 88.01% to 0.51 in 2023, then soared by 32.44% to 0.67 in 2024, then skyrocketed by 98.72% to 1.34 in 2025.
  • The last three reported values for Debt Ratio were 1.34 (Q3 2025), 1.02 (Q2 2025), and 0.87 (Q1 2025) per Business Quant data.